The efficiency of infection receptor use is the first step in determining the species tropism of viruses. After the coronavirus disease 2019 pandemic, a number of SARS-CoV-2-related coronaviruses (SC2r-CoVs) were identified in bats, and some of them can use human angiotensin converting enzyme 2 (ACE2) for the infection receptor without acquiring additional mutations. This means that the potential of certain SC2r-CoVs to cause spillover from bats to humans is "off-the-shelf." However, both SC2r-CoVs and bat species are highly diversified, and the host tropism of SC2r-CoVs remains unclear. Here, we focus on two Laotian SC2r-CoVs, BANAL-20-236 and BANAL-20-52, and determine how the tropism of SC2r-CoVs to bat ACE2 is determined at the amino acid resolution level.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779674 | PMC |
| http://dx.doi.org/10.1128/jvi.00990-23 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses.
PLoS Pathog
November 2024
Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
Article Synopsis
- Understanding bat coronaviruses (CoVs) is vital for preventing future pandemics, so researchers created modified viruses to study how these bat CoVs enter cells.
- They discovered a surprising change in a specific region of the virus that improved its ability to bind to a human receptor, enhancing its entry into cells.
- The study reveals how bat CoVs might adapt to jump between species and suggests strategies to target vulnerabilities in these viruses for potential prevention measures.
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization.
PLoS Pathog
November 2024
Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.
The COVID-19 pandemic, caused by SARS-CoV-2, demonstrated that zoonotic transmission of animal sarbecoviruses threatens human health but the determinants of transmission are incompletely understood. Here, we show that most spike (S) proteins of horseshoe bat and Malayan pangolin sarbecoviruses employ ACE2 for entry, with human and raccoon dog ACE2 exhibiting broad receptor activity. The insertion of a multibasic cleavage site into the S proteins increased entry into human lung cells driven by most S proteins tested, suggesting that acquisition of a multibasic cleavage site might increase infectivity of diverse animal sarbecoviruses for the human respiratory tract.
View Article and Find Full Text PDFAbortive infection of bat fibroblasts with SARS-CoV-2.
Proc Natl Acad Sci U S A
October 2024
Whitehead Institute for Biomedical Research, Cambridge, MA 02142.
Bats are tolerant to highly pathogenic viruses such as Marburg, Ebola, and Nipah, suggesting the presence of a unique immune tolerance toward viral infection. Here, we compared severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of human and bat () pluripotent cells and fibroblasts. Since bat cells do not express an angiotensin-converting enzyme 2 (ACE2) receptor that allows virus infection, we transduced the human ACE2 (hA) receptor into the cells and found that transduced cells can be infected with SARS-CoV-2.
View Article and Find Full Text PDFIdentification and genetic characterization of five novel bat coronaviruses from Yunnan, China.
BMC Vet Res
October 2024
Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, 650500, P. R. China.
Article Synopsis
- - Coronaviruses (CoVs) pose a significant healthcare challenge due to their ability to cause diseases in humans, and bats are potential hosts for these zoonotic viruses, with increasing cases of novel CoVs identified in them.
- - A study analyzing 61 bats in Yunnan Province found seven CoVs, revealing varied genetic structures and unique recombination patterns that increase the risk of transmission to other species, including civets and pangolins.
- - The research highlights the high diversity of CoVs in bats and indicates that ongoing monitoring of these animals is crucial to prevent potential outbreaks of new viral infections in humans.
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.
Cell
December 2024
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Electronic address:
Article Synopsis
- - SARS-CoV-2 has evolved to evade current monoclonal antibodies (mAbs), emphasizing the need for more resilient treatments that can neutralize various viral strains.
- - A new human mAb called VIR-7229 has shown the ability to effectively neutralize multiple variants of SARS-CoV-2 and other related viruses, due to its unique targeting of a critical viral region known as the receptor-binding motif (RBM).
- - VIR-7229 demonstrates a high resistance to the emergence of virus escape mutants, making it a promising candidate for future therapies against evolving coronaviruses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!